CURE10h
Aligning Treatment Goals: Key Considerations for Patients and Caregivers in Late-Line RRMM
Panelists discuss how quality of life priorities shift in late-line multiple myeloma treatment, with patients emphasizing the ...
Cutting Medicaid could worsen overdose deaths — and erase recent progress in treating addiction
Reducing funding to the largest payer for addiction services could pose major setbacks for those battling drug use ...
Nature6y
HIV: Progress and future challenges in treatment, prevention and cure
1 Innovations in treatment and access are at the core of this progress. The advent of antiretroviral therapy (ART), once-daily single tablet regimens (STRs) with three medications combined into ...
Salem News1d
Salem utilities officials talk wastewater treatment plant project progress
The utilities commission discussed the rate of progress for phase three improvements at the wastewater treatment plant in its meeting Thursday. Burgess and Niple Contract Administrator Don Tych said ...
Study shows significant progress in HIV treatment initiation in the Asia-Pacific region
In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...
Seacoastonline5dOpinion
Commentary: Changes to Medicaid jeopardize our progress on mental health
The 60-year-old Medicaid system, signed into law by President Lyndon B. Johnson in 1965, ensures that individuals have access ...
Neurology Advisor10d
Atogepant Treatment Reduces Migraine Symptoms As Early As Day 1
Atogepant vs placebo for the preventative treatment of migraine alleviated migraine symptoms across 3 clinical trials on day 1.
Business Wire18d
AAD 2025: Almirall presents early-stage pipeline progress and real-world evidence on demonstrating AK treatment success and patient satisfaction with Tirbanibulin
a topical treatment for actinic keratosis (AK) and progress of its early-stage asset LAD191, a high-affinity monoclonal antibody targeting interleukin-1 receptor accessory protein (IL-1RAP).